TLDR
- Following a roughly 22% decline in 2026, UBS has shifted its stance on IBM from Sell to Neutral, noting improved risk/reward balance
- The tech giant currently trades at approximately 18.5x its projected 2026 EPS of $12.43, representing a mid-teens discount versus broader market multiples
- The stock’s downturn stemmed primarily from Anthropic’s Claude Code unveiling COBOL modernization capabilities, raising concerns about IBM’s mainframe operations
- Fourth-quarter results exceeded expectations with $4.52 EPS versus $4.33 consensus, alongside $19.69B revenue — a 12.2% year-over-year increase
- Wall Street consensus stands at Moderate Buy with analysts targeting an average price of $330.07
UBS has reversed its bearish position on International Business Machines (IBM), elevating the rating to Neutral from Sell following a significant downturn in early 2026 that has created a more attractive risk/reward profile.
International Business Machines Corporation, IBM
The computing giant has shed approximately 22% of its value year-to-date and has lagged the S&P 500 by nearly 27% over the trailing twelve months.
Shares began trading Wednesday at $229.34, significantly below the 52-week peak of $324.90.
A substantial portion of the recent weakness can be attributed to a single trading session. On February 23, IBM plummeted roughly 13% following Anthropic’s announcement that its Claude Code platform would incorporate COBOL modernization features — igniting concerns that artificial intelligence could automate legacy systems and erode IBM’s mainframe and consulting revenues.
Multiple analysts, including teams at Wedbush and Evercore, characterized the selloff as excessive. They highlighted IBM’s robust customer retention and the substantial complexity involved in mainframe migration as evidence the competitive threat may be exaggerated.
UBS aligned with this perspective, suggesting the competitive challenges facing IBM’s Z mainframe platform appear largely reflected in current valuations. The investment bank pointed to customer retention dynamics, data sovereignty mandates, and IBM’s comprehensive vertically integrated technology stack — featuring quantum-resistant cryptography — as factors making mainframe displacement improbable in the foreseeable future.
What the Numbers Look Like Now
IBM currently commands a valuation of approximately 18.5 times its projected 2026 earnings per share of $12.43 and 17.5 times its 2027 forecast of $13.13. This represents a mid-teens valuation discount relative to broader market multiples.
UBS maintained its $236 price objective, calculated using 18 times its 2027 EPS projection. Under an optimistic scenario, UBS envisions shares reaching $312 if software revenue accelerates and profit margins widen. In a pessimistic scenario, the stock could decline to $134 if AI-powered coding solutions significantly disrupt IBM’s software and infrastructure revenue streams.
IBM has provided guidance for 2026 free cash flow of $15.7 billion, translating to approximately $16.25 per share — representing roughly a 7% free cash flow yield. UBS noted this aligns with comparable large-cap software companies experiencing mid-single-digit revenue growth.
UBS projects IBM will achieve 3% to 4% organic revenue expansion over the coming years. The firm identified decelerating growth at Red Hat, ambiguity surrounding the Consulting division as artificial intelligence transforms client demand, and persistent headwinds affecting IBM’s infrastructure segment as continuing challenges.
Q4 Results and Analyst Ratings
IBM’s latest quarterly performance demonstrated strength. The technology leader posted Q4 EPS of $4.52, surpassing the $4.33 analyst consensus. Revenue reached $19.69 billion, exceeding projections of $19.23 billion and representing a 12.2% year-over-year gain.
IBM also announced a quarterly dividend of $1.68 per share, scheduled for March 10 distribution. This translates to an annualized dividend yield of approximately 2.9%.
Board member David N. Farr purchased 1,000 shares at $304.00 on January 30, expanding his total position to 9,258 shares.
Vestmark Advisory Solutions dramatically expanded its IBM position by 413.7% during Q3, acquiring 6,209 shares to reach a total holding of 7,710.
Among Wall Street analysts, IBM maintains a consensus Moderate Buy rating with an average price objective of $330.07, derived from one Strong Buy, eleven Buy, seven Hold, and one Sell recommendation.
